info icon

Any event in hilmo or specialist outpatient

ANY_HILMO

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 ANY
  • Hospital discharge: ICD-9 ANY
  • Hospital discharge: ICD-8 ANY

1 out of 7 registries used, show all original rules.

516428

4. Check minimum number of events

None

516428

5. Include endpoints

None

516428

6. Filter based on genotype QC (FinnGen only)

516428

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF2

Case counts by codes

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 516428 292086 224342
Unadjusted period prevalence (%) 99.27 99.56 98.90
Median age at first event (years) 25.90 22.65 30.13

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

No data available

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
225
56
31.75
206.16
5.1
1.9
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
294
200
13.10
177.61
6.3
2.4
mmol/l
6.5
6.9
1.06
273
170
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
379
408
9.92
168.23
7.5
1.5
u/l
77.8
71.9
0.94
360
372
(3032080) INR in Blood by Coagulation assay
173
46
26.81
153.16
8.5
2.9
inr
1.1
1.1
0.02
51
17
(3044640) Blood type and Crossmatch panel - Blood
150
21
49.09
152.88
2.7
1.4
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
243
151
12.89
152.13
6.9
1.4
umol/l
10.9
12.7
0.94
235
142
(3013650) Neutrophils [#/volume] in Blood by Automated count
310
319
8.72
138.06
9.2
1.9
e9/l
4.1
3.7
1.66
276
283
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
177
74
17.06
132.90
8.9
2.1
mmol/l
1.2
1.2
0.09
167
64
(3003694) ABO and Rh group [Type] in Blood
170
71
16.86
127.42
1.6
1.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
554
1180
8.77
126.68
12.7
2.1
mg/l
23.1
21.4
0.40
422
663
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
189
104
13.16
124.39
10.9
2.0
mmol/l
1.2
1.2
1.12
167
96
(3013707) Erythrocyte sedimentation rate by Westergren method
372
541
6.89
120.89
3.6
1.6
mm/h
8.2
6.7
1.70
349
493
(3023368) Bacteria identified in Blood by Culture
121
19
41.56
119.89
5.5
2.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
153
63
16.59
114.77
2.4
1.3
e6/l
23.4
10.5
0.68
124
42
(3031040) Bacteria [#/volume] in Urine by Automated count
294
361
6.93
109.63
4.0
1.4
e6/l
85.9
1583.6
—
10
5
(3024561) Albumin [Mass/volume] in Serum or Plasma
176
106
11.71
109.49
6.0
1.5
g/l
36.4
39.7
5.31
170
99
(3019550) Sodium [Moles/volume] in Serum or Plasma
521
1144
6.95
109.39
14.8
2.4
mmol/l
139.6
140.2
6.64
503
1069
(3023103) Potassium [Moles/volume] in Serum or Plasma
524
1168
6.91
107.72
14.9
2.5
mmol/l
4.0
4.0
2.93
505
1094
(3018095) Leukocytes [#/volume] in Urine
175
109
11.29
106.64
3.1
1.4
e6/l
51.0
299.0
0.63
129
62
(3037467) Urinalysis macro (dipstick) panel - Urine
338
501
6.19
104.99
4.1
1.5
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
155
81
13.06
103.68
6.2
2.4
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
256
284
7.16
103.47
5.7
1.7
e9/l
0.6
0.6
0.25
229
253
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
164
96
11.81
103.30
2.6
1.2
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
254
285
7.04
101.44
5.8
1.7
e9/l
0.0
0.0
0.10
229
252
(3021589) Normoblasts [#/volume] in Blood
240
252
7.36
101.33
8.3
2.3
e9/l
0.0
0.0
0.50
191
199
(3019198) Lymphocytes [#/volume] in Blood
268
322
6.72
100.73
5.7
1.7
e9/l
1.8
2.0
2.91
245
292
(3013115) Eosinophils [#/volume] in Blood
259
306
6.73
98.55
6.0
1.7
e9/l
0.2
0.2
0.03
236
279
(3030467) Casts [#/volume] in Urine by Automated count
129
52
16.28
96.94
2.4
1.4
e6/l
0.3
0.3
0.08
101
33
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
102
20
32.20
95.97
2.9
1.3
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
231
248
7.07
95.12
5.7
1.5
%
0.7
0.7
0.17
218
231
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
174
129
9.42
94.53
3.8
1.3
ng/l
35.4
62.7
0.21
103
30
(3019069) Monocytes/100 leukocytes in Blood
240
272
6.78
94.24
6.0
1.9
%
8.4
8.0
0.70
230
257
(3006504) Eosinophils/100 leukocytes in Blood
237
270
6.71
92.45
5.8
1.7
%
2.9
3.2
0.75
224
254
(36304419) Bacteria [Presence] in Urine
129
58
14.57
92.27
2.2
1.3
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
108
32
21.46
90.68
3.0
1.2
ng/l
713.4
482.8
0.66
91
24
(3002030) Lymphocytes/100 leukocytes in Blood
253
321
6.15
89.08
5.7
1.8
%
27.9
32.2
6.15
242
300
(3033658) Prothrombin time (PT) actual/Normal
112
39
18.35
88.87
3.3
1.6
%
93.6
90.9
0.27
112
39
(3002385) Erythrocyte distribution width [Ratio]
484
1126
5.43
88.30
14.7
2.4
%
13.3
13.5
0.93
476
1067
(3018010) Neutrophils/100 leukocytes in Blood
248
311
6.17
88.18
5.5
1.6
%
58.1
53.8
4.90
238
295
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
154
108
9.64
86.28
3.3
1.2
u/l
56.1
68.4
0.70
149
102
(3000850) Epithelial cells [#/volume] in Urine
101
34
18.65
80.91
2.1
1.4
e6/l
4.6
2.9
0.91
96
24
(3026782) Osmolality of Urine
90
24
23.18
77.76
2.1
1.2
mosm/kgh2o
582.9
597.8
0.08
83
15
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
499
1289
4.94
75.96
10.6
2.1
ml/min/173m2
91.9
91.1
0.29
395
938
(40761511) CBC panel - Blood by Automated count
578
1710
6.07
73.93
11.2
2.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
121
74
10.51
73.16
8.0
1.8
—
—
—
0
0
(3044889) 12 lead EKG panel
326
620
4.49
71.55
3.4
1.6
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
372
788
4.37
71.30
3.5
1.9
pmol/l
14.8
14.6
0.74
346
691
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
457
1137
4.47
71.19
4.1
2.0
mu/l
1.8
2.0
1.62
431
1052
(3035350) Ketones [Presence] in Urine by Test strip
248
378
4.98
70.26
3.1
1.4
estimate
0.0
0.0
0.00
48
34
(3009261) Glucose [Presence] in Urine by Test strip
250
384
4.95
70.22
3.2
1.4
estimate
0.0
0.0
0.00
44
31
(3015377) Calcium [Moles/volume] in Serum or Plasma
137
111
8.08
68.75
3.1
1.2
mmol/l
2.4
2.4
0.55
123
97
(3021601) Nitrite [Presence] in Urine by Test strip
246
379
4.90
68.66
4.3
2.1
estimate
0.0
0.0
0.00
47
34
(3026008) Bacteria identified in Urine by Culture
115
77
9.50
65.53
2.9
1.2
—
—
—
0
0
(3013512) EKG study
120
87
8.82
64.91
3.6
1.8
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
133
112
7.72
64.68
1.8
1.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
84
31
16.55
64.63
2.8
1.3
ng/l
124.6
3997.5
0.46
55
17
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
76
24
19.13
61.87
2.0
1.5
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
184
244
5.20
59.45
3.1
1.5
u/l
28.8
28.8
0.00
175
239
(3015736) pH of Urine
192
266
5.02
59.21
2.9
1.5
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
175
231
5.15
56.58
1.8
1.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
109
84
8.15
56.22
1.6
1.1
mg/l
0.9
0.3
1.70
88
58
(3042936) Bacteria identified in Isolate by Culture
66
19
20.68
55.29
2.8
1.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
71
27
15.74
53.76
2.3
1.3
e6/l
2.0
0.3
0.73
39
13
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
578
1935
4.77
53.49
9.1
2.3
u/l
28.4
27.3
0.73
559
1859
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
58
12
28.46
53.24
1.6
1.3
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
72
29
14.88
53.22
2.2
1.3
e6/l
0.7
0.6
0.07
40
14
(3007461) Platelets [#/volume] in Blood
622
2229
6.11
52.02
17.8
2.9
e9/l
244.5
253.6
3.14
610
2123
(3010813) Leukocytes [#/volume] in Blood
624
2252
6.15
51.29
17.9
2.9
e9/l
6.6
6.1
8.16
613
2134
(3035941) MCH [Entitic mass]
623
2247
6.08
51.17
17.6
2.9
pg
30.2
30.0
2.24
614
2183
(3024731) MCV [Entitic volume]
623
2247
6.08
51.17
17.7
2.9
fl
90.0
89.1
4.72
614
2182
(3026361) Erythrocytes [#/volume] in Blood
623
2249
6.07
51.02
17.7
2.9
e12/l
4.7
4.8
14.28
612
2136
(3000963) Hemoglobin [Mass/volume] in Blood
624
2257
6.12
50.92
17.8
2.9
g/l
140.0
144.8
12.02
615
2193
(3019309) Folate [Moles/volume] in Red Blood Cells
65
23
16.78
50.58
1.7
1.1
nmol/l
1024.6
996.8
0.06
53
16
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
56
13
25.28
49.87
1.6
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
171
258
4.44
46.94
2.1
1.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
193
326
4.06
46.05
3.1
1.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
131
165
5.07
43.71
3.2
1.6
estimate
0.0
0.0
0.49
44
33
(3011397) Hemoglobin [Presence] in Urine by Test strip
112
121
5.78
43.45
3.2
1.4
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
91
80
6.94
42.11
1.9
1.4
mg/l
2.7
2.6
0.07
83
66
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
181
311
3.91
41.84
2.3
1.3
nmol/l
70.4
71.9
0.24
164
294
(3017143) Hepatitis C virus Ab [Presence] in Serum
97
96
6.20
40.62
1.7
1.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
63
35
10.62
39.59
1.6
1.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
473
1533
3.12
39.50
3.7
2.2
mmol/l
5.8
5.6
3.93
444
1441
(40768797) Stomach Pathology biopsy report
56
25
13.10
39.34
1.3
1.0
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
122
158
4.86
39.31
1.3
1.1
g/l
2.5
2.3
0.54
76
117
(3001122) Ferritin [Mass/volume] in Serum or Plasma
209
419
3.44
38.61
2.4
1.7
ug/l
132.6
64.6
3.40
193
402
(3021960) Folate [Moles/volume] in Serum or Plasma
85
81
6.33
36.66
1.3
1.1
nmol/l
21.0
20.4
0.12
76
72
(3048689) Calprotectin [Mass/mass] in Stool
83
77
6.49
36.62
2.3
1.2
ug/g
133.8
100.0
0.30
65
62
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
141
220
4.10
36.46
1.8
1.2
pmol/l
89.6
93.6
0.43
77
115
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
447
1440
2.92
36.46
4.6
2.7
mmol/mol
39.1
36.8
5.46
428
1379
(3012516) Albumin [Mass/volume] in Urine
120
164
4.58
36.30
3.2
2.4
mg/l
125.5
143.1
0.05
77
101
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
129
188
4.34
36.23
1.3
1.1
u/ml
1.1
1.9
0.41
38
51
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
54
27
11.65
35.84
1.5
1.0
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
79
71
6.67
35.76
1.3
1.1
u/ml
4.3
12.1
0.46
30
34
(3020682) Albumin/Creatinine [Ratio] in Urine
127
185
4.33
35.65
3.8
2.9
mg/mmol
16.7
7.4
0.61
83
133
(3041096) Erythrocytes [Presence] in Urine by Automated
148
244
3.90
35.62
2.7
1.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
82
78
6.32
35.39
1.3
1.0
iu/ml
14.0
20.5
0.45
27
23
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
40
10
22.91
34.72
2.6
1.5
—
—
—
0
0
(3012544) pH of Venous blood
40
10
22.91
34.72
4.4
1.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
118
165
4.46
34.70
3.1
1.5
kg/l
1.0
1.0
—
10
17
(3019832) Treponema pallidum Ab [Presence] in Serum
99
120
5.04
33.99
1.9
1.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
144
243
3.79
33.46
2.8
2.0
mmol/l
9.0
10.0
0.99
126
211
(3002256) Pathology report gross observation
49
24
11.81
32.83
1.2
1.0
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
523
1900
3.01
32.58
3.9
2.4
mmol/l
2.8
3.1
14.67
495
1819
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
38
10
21.70
32.47
1.9
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
502
1786
2.90
32.36
3.4
2.3
mmol/l
1.3
1.3
0.54
476
1716
(3009542) Hematocrit [Volume Fraction] of Blood
528
1932
3.03
32.35
12.7
2.6
%
41.2
42.3
2.52
446
1727
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
515
1876
2.91
31.20
3.6
2.4
mmol/l
1.4
1.4
3.12
489
1803
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
515
1884
2.88
30.69
3.7
2.4
mmol/l
4.6
5.0
16.05
491
1812
(40760892) CBC W Ordered Manual Differential panel - Blood
122
197
3.86
29.84
4.5
1.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
404
1317
2.59
29.75
3.1
1.6
u/l
41.8
32.8
2.32
391
1283
(3050129) First trimester maternal screen panel - Serum or Plasma
38
15
14.45
28.07
1.4
1.1
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
125
223
3.48
26.50
2.9
1.5
umol/l
6674.5
3281.9
0.31
116
211
(3022145) Colonoscopy Study observation
49
35
8.08
26.21
1.4
1.1
—
—
—
0
0
(3000991) Gas panel - Venous blood
39
5
44.64
26.18
8.1
5.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
58
52
6.50
26.16
1.7
1.3
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
41
7
33.58
26.14
4.4
1.4
ug/l
17.4
1.5
—
33
7
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
33
13
14.37
24.35
1.6
1.0
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
202
506
2.64
24.11
4.0
1.9
ug/l
2.1
1.7
0.78
183
473
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
68
83
4.81
22.94
2.2
1.4
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
36
20
10.22
22.47
3.6
1.2
pmol/l
4.5
4.9
0.72
30
15
(3019225) pH of Specimen
32
15
12.06
21.81
5.4
1.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
32
15
12.06
21.81
3.0
1.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
77
111
4.10
21.48
1.8
1.4
pmol/l
382.4
383.1
0.01
70
104
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
29
12
13.61
20.92
1.6
1.0
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
29
12
13.61
20.92
1.6
1.0
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
29
12
13.61
20.92
1.6
1.0
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
29
12
13.61
20.92
1.6
1.0
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
41
32
7.31
20.55
2.9
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
28
12
13.12
19.88
1.5
1.0
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
439
1662
2.18
19.39
3.7
2.7
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
26
12
12.14
17.82
1.5
1.0
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
26
12
12.14
17.82
1.5
1.0
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
113
246
2.78
17.00
1.7
1.3
mmol/l
1.5
1.4
0.18
98
223
(3008898) HLA-B27 [Presence]
28
17
9.25
16.56
1.0
1.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
135
330
2.51
16.25
1.6
1.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
159
421
2.36
16.17
4.1
2.0
%
20.3
24.8
2.50
63
135
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
43
49
5.00
15.52
7.5
1.7
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
19
0
+∞
15.42
1.8
0.0
ug/l
13.4
—
—
19
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
124
302
2.49
14.95
2.5
1.7
—
—
—
0
0
(4010399)
30
25
6.74
14.29
1.4
1.2
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
23
5
25.68
14.04
3.1
2.0
%
60.2
29.4
—
23
5
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
23
5
25.68
14.04
4.0
1.2
mmol/l
1.2
1.2
—
23
5
(3000330) Specific gravity of Urine by Test strip
24
15
8.93
13.94
2.6
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
33
32
5.81
13.87
1.4
1.0
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
36
39
5.21
13.66
2.6
1.8
e9/l
4.1
4.2
0.08
31
32
(3000494) Fungus identified in Specimen by Culture
62
107
3.35
13.51
1.7
1.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
28
23
6.82
13.48
1.2
1.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
23
6
21.39
13.43
2.2
1.3
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
34
36
5.32
13.19
1.1
1.1
u/ml
997.3
116.2
0.59
28
31
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
16
0
+∞
12.98
2.5
0.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
43
58
4.21
12.93
1.0
1.0
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
23
7
18.35
12.86
1.8
1.6
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
110
272
2.41
12.75
2.3
1.6
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
47
70
3.83
12.52
3.8
2.1
%
30.8
31.8
0.19
36
38
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
20
12
9.26
11.89
1.4
1.0
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
26
23
6.32
11.81
1.5
1.8
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
35
43
4.59
11.69
1.2
1.0
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
119
317
2.25
11.65
2.6
1.7
ug/l
0.8
0.7
0.37
72
127
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
31
34
5.12
11.63
2.5
1.9
—
8.1
—
0
9
(36660697) Celiac disease serology panel - Serum
40
58
3.90
11.03
1.1
1.0
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
23
19
6.74
11.03
1.3
1.3
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
39
57
3.86
10.65
1.2
1.1
iu/ml
72.2
174.2
1.44
14
29
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
13
0
+∞
10.53
1.7
0.0
mg/l
10.0
—
—
13
0
(3022621) pH of Urine by Test strip
32
40
4.49
10.50
2.1
1.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
19
7
15.06
10.08
1.9
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
63
132
2.74
10.03
1.4
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
28
33
4.74
9.78
1.1
1.1
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
17
5
18.81
9.71
1.4
2.0
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
94
244
2.26
9.70
1.9
1.2
%
1.4
1.0
5.31
85
231
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
16
5
17.69
9.00
1.4
1.0
—
—
—
0
0
(3000492) Spirometry study
63
142
2.54
8.75
1.4
1.3
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
18
9
11.07
8.55
1.6
1.3
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
15
10
8.27
8.33
1.3
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
17
8
11.75
8.30
1.5
1.0
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
36
60
3.37
8.28
1.7
1.3
nmol/l
35.6
42.4
1.19
36
60
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
10
0
+∞
8.09
3.5
0.0
nmol/l
2.5
—
—
10
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
32
51
3.51
7.84
2.2
1.3
ml/min/173m2
70.5
88.2
1.03
13
11
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
15
11
7.52
7.82
3.5
1.9
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
17
15
6.26
7.74
1.2
1.1
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
16
8
11.04
7.65
2.2
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
66
165
2.29
7.39
2.1
1.7
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
16
14
6.31
7.33
1.5
1.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
9
0
+∞
7.28
6.7
0.0
%
50.7
—
—
9
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
9
0
+∞
7.28
1.0
0.0
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
9
0
+∞
7.28
6.6
0.0
e9/l
2.8
—
—
9
0
(3027315) Oxygen [Partial pressure] in Blood
9
0
+∞
7.28
3.1
0.0
kpa
9.2
—
—
9
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
9
0
+∞
7.28
1.4
0.0
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
9
0
+∞
7.28
3.1
0.0
kpa
5.1
—
—
9
0
(1761482) Bacteria [#/volume] in Urine by Culture
14
6
12.85
7.16
3.6
1.2
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
14
6
12.85
7.16
3.0
1.3
g/l
10.8
9.3
—
14
6
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
13
5
14.30
6.93
3.2
2.0
g/l
0.1
0.0
—
13
5
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
13
5
14.30
6.93
3.2
2.0
g/l
0.0
0.0
—
13
5
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
14
7
11.01
6.75
3.0
1.7
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
15
9
9.19
6.65
2.6
2.1
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
13
6
11.91
6.50
3.2
1.8
g/l
3.2
3.1
—
13
6
(3033705) Calcium.ionized [Moles/volume] in Venous blood
8
0
+∞
6.47
3.7
0.0
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
8
0
+∞
6.47
3.7
0.0
mmol/l
4.0
—
—
8
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
8
0
+∞
6.47
1.8
0.0
nmol/l
0.4
—
—
8
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
8
0
+∞
6.47
1.5
0.0
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
8
0
+∞
6.47
3.8
0.0
mmol/l
107.4
—
—
8
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
8
0
+∞
6.47
1.8
0.0
—
—
—
0
0
(40768443) Skin Pathology biopsy report
18
21
4.74
6.38
1.1
1.0
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
14
8
9.64
6.38
1.4
1.0
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
12
5
13.19
6.26
1.0
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
16
17
5.19
6.21
1.2
1.0
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
16
17
5.19
6.21
1.2
1.0
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
14
13
5.93
6.11
1.3
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
17
20
4.69
5.98
1.6
1.5
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
7
0
+∞
5.66
1.3
0.0
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
7
0
+∞
5.66
1.3
0.0
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
7
0
+∞
5.66
2.4
0.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
7
0
+∞
5.66
1.3
0.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
53
136
2.20
5.62
1.9
1.5
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
11
5
12.07
5.59
1.2
1.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
11
5
12.07
5.59
1.5
2.2
—
—
—
0
0
(1002224) Polysomnography panel
25
43
3.23
5.54
1.1
1.0
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
12
7
9.42
5.48
1.8
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
20
30
3.69
5.35
1.8
1.9
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
13
13
5.50
5.33
1.2
1.0
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
15
18
4.59
5.18
1.2
1.0
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
82
258
1.82
5.02
1.4
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
6
0
+∞
4.85
1.3
0.0
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
6
0
+∞
4.85
10.0
0.0
umol/l
30.5
—
—
6
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
6
0
+∞
4.85
3.2
0.0
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
6
0
+∞
4.85
3.2
0.0
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
6
0
+∞
4.85
1.8
0.0
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
6
0
+∞
4.85
5.2
0.0
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
6
0
+∞
4.85
1.2
0.0
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
6
0
+∞
4.85
7.2
0.0
mmol/l
0.5
—
—
6
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
6
0
+∞
4.85
1.2
0.0
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
6
0
+∞
4.85
3.2
0.0
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
0
+∞
4.85
1.5
0.0
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
6
0
+∞
4.85
1.0
0.0
mmol/l
69.5
—
—
6
0
(4062490)
6
0
+∞
4.85
1.2
0.0
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
6
0
+∞
4.85
1.5
0.0
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
6
0
+∞
4.85
3.2
0.0
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
6
0
+∞
4.85
3.2
0.0
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
6
0
+∞
4.85
1.5
0.0
mmol/l
2.1
—
—
6
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
6
0
+∞
4.85
1.3
0.0
u/l
1904.0
—
—
6
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
6
0
+∞
4.85
3.2
0.0
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
13
15
4.76
4.67
2.3
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
0
+∞
4.04
2.6
0.0
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
5
0
+∞
4.04
1.8
0.0
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
5
0
+∞
4.04
2.2
0.0
nmol/l
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
5
0
+∞
4.04
1.4
0.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
0
+∞
4.04
1.0
0.0
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
0
+∞
4.04
1.0
0.0
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
5
0
+∞
4.04
1.6
0.0
%
93.1
—
—
5
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
5
0
+∞
4.04
1.0
0.0
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
5
0
+∞
4.04
2.6
0.0
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
5
0
+∞
4.04
3.4
0.0
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
0
+∞
4.04
1.2
0.0
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
5
0
+∞
4.04
1.8
0.0
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
5
0
+∞
4.04
1.2
0.0
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
5
0
+∞
4.04
3.8
0.0
nmol/l
42.2
—
—
5
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
5
0
+∞
4.04
1.0
0.0
ug/l
7.1
—
—
5
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
14
20
3.85
4.00
2.1
1.9
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
10
8
6.84
3.97
1.0
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
208
870
1.42
3.84
2.5
1.9
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
14
21
3.66
3.77
1.2
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
9
7
7.03
3.68
1.1
1.0
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
11
15
4.02
3.32
1.1
1.1
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
7
5
7.64
3.08
1.4
1.0
iu/ml
122.3
159.5
—
7
5
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
7
5
7.64
3.08
1.0
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
15
28
2.94
3.00
1.1
1.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
9
10
4.92
2.96
1.1
1.0
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
25
62
2.23
2.96
1.6
1.3
miu/ml
153.7
205.8
—
10
40
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
13
23
3.10
2.82
1.4
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
13
23
3.10
2.82
1.4
1.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
7
6
6.36
2.80
4.3
1.2
—
—
—
0
0
(4034850)
17
36
2.59
2.77
11.3
2.2
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
8
9
4.85
2.66
1.3
1.0
ug/l
4.5
2.8
—
8
9
(4094501)
9
12
4.10
2.59
1.0
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
7
7
5.45
2.56
1.0
1.1
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
7
7
5.45
2.56
1.0
1.0
nmol/l
29.8
32.5
—
7
7
(3015183) Erythrocyte sedimentation rate
6
5
6.54
2.49
1.2
1.0
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
33
99
1.84
2.43
1.4
1.2
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
6
8
4.08
1.86
1.0
1.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
35
117
1.65
1.85
1.2
1.4
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
14
3.12
1.85
1.0
1.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
25
76
1.81
1.82
2.0
1.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
5
6
4.53
1.73
1.2
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
7
12
3.18
1.70
1.1
1.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
40
142
1.56
1.69
1.5
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
38
136
1.54
1.56
1.8
1.6
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
7
3.88
1.56
1.2
1.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
6
10
3.27
1.55
1.2
1.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
12
30
2.18
1.46
1.9
1.0
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
11
27
2.22
1.40
1.1
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
42
160
1.45
1.32
1.5
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
42
161
1.44
1.29
1.5
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
42
161
1.44
1.29
1.5
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
42
162
1.43
1.25
1.5
1.2
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
7
16
2.38
1.12
1.3
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
20
67
1.63
1.11
1.2
1.7
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
18
64
1.54
0.83
1.5
1.4
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
9
30
1.63
0.73
1.2
1.0
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
9
30
1.63
0.73
1.2
1.0
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
11
36
1.66
0.70
1.1
1.1
u/ml
0.9
4.3
—
5
11
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
12
42
1.56
0.61
1.3
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
87
525
0.88
0.47
1.4
1.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
44
272
0.87
0.36
1.4
1.3
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
21
95
1.20
0.27
1.5
1.2
mg/l
3.3
2.1
0.41
12
51
(3041806) Other cells [#/volume] in Blood by Manual count
5
21
1.29
0.23
1.0
1.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
63
367
0.92
0.21
1.8
1.5
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
5
26
1.04
0.09
2.0
1.1
g/l
0.9
1.0
—
5
26
(3001019) Free T4 and TSH panel - Serum or Plasma
23
117
1.07
0.06
1.9
1.4
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
40.3
—
0
5
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

Index endpoint: ANY_HILMO – Any event in hilmo or specialist outpatient

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).